Product References
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway.
Molecular therapy oncolytics
Wei L,Yang Y,Gupta P,Wang A,Zhao M,Zhao Y,Qu M,Ke Y,Liu Y,Liu HM,Xu X,Sun Y,Chen ZS,Hu Z
13-0611 was used in Flow cytometry/Cell sorting to highlight that OGP46 is active against not only native BCR-ABL but also 11 clinically relevant BCR-ABL mutations, including T315I mutation, which are resistant to imatinib.
Fri Sep 25 00:00:00 EDT 2020
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway.
Molecular therapy oncolytics
Wei L,Yang Y,Gupta P,Wang A,Zhao M,Zhao Y,Qu M,Ke Y,Liu Y,Liu HM,Xu X,Sun Y,Chen ZS,Hu Z
13-0611 was used in Flow cytometry/Cell sorting to highlight that OGP46 is active against not only native BCR-ABL but also 11 clinically relevant BCR-ABL mutations, including T315I mutation, which are resistant to imatinib.
Fri Sep 25 00:00:00 EDT 2020
Polychromic Reporter Mice Reveal Unappreciated Innate Lymphoid Cell Progenitor Heterogeneity and Elusive ILC3 Progenitors in Bone Marrow.
Immunity
Walker JA,Clark PA,Crisp A,Barlow JL,Szeto A,Ferreira ACF,Rana BMJ,Jolin HE,Rodriguez-Rodriguez N,Sivasubramaniam M,Pannell R,Cruickshank J,Daly M,Haim-Vilmovsky L,Teichmann SA,McKenzie ANJ
13-0611-81 was used in Flow Cytometry to identify a discrete ILC2-committed population and delineated transition states between early progenitors and a highly heterogeneous ILC1, ILC3, and NK precursor cell cluster.
Tue Jul 16 00:00:00 EDT 2019
Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease.
The Journal of pathology
Dukinfield M,Maniati E,Reynolds LE,Aubdool A,Baliga RS,D'Amico G,Maiques O,Wang J,Bedi KC,Margulies KB,Sanz-Moreno V,Hobbs A,Hodivala-Dilke K
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Immunohistochemistry
Sun Dec 01 00:00:00 EST 2019
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
Cancer cell
Mohr S,Doebele C,Comoglio F,Berg T,Beck J,Bohnenberger H,Alexe G,Corso J,Ströbel P,Wachter A,Beissbarth T,Schnütgen F,Cremer A,Haetscher N,Göllner S,Rouhi A,Palmqvist L,Rieger MA,Schroeder T,Bönig H,Müller-Tidow C,Kuchenbauer F,Schütz E,Green AR,Urlaub H,Stegmaier K,Humphries RK,Serve H,Oellerich T
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Flow Cytometry
Mon Apr 10 00:00:00 EDT 2017
The fibronectin synergy site re-enforces cell adhesion and mediates a crosstalk between integrin classes.
eLife
Benito-Jardón M,Klapproth S,Gimeno-LLuch I,Petzold T,Bharadwaj M,Müller DJ,Zuchtriegel G,Reichel CA,Costell M
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Flow Cytometry
Mon Jan 16 00:00:00 EST 2017
The fibronectin synergy site re-enforces cell adhesion and mediates a crosstalk between integrin classes.
eLife
Benito-Jardón M,Klapproth S,Gimeno-LLuch I,Petzold T,Bharadwaj M,Müller DJ,Zuchtriegel G,Reichel CA,Costell M
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Flow Cytometry
Mon Jan 16 00:00:00 EST 2017
Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Breast cancer research and treatment
Yeo SK,French R,Spada F,Clarkson R
13-0611-81 was used in Flow cytometry/Cell sorting to indicate that inhibiting the processing of p100 may be a potential therapeutic strategy to suppress cancer stem cell (CSC) activity in a subset of breast tumours.
Sat Apr 01 00:00:00 EDT 2017
Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Breast cancer research and treatment
Yeo SK,French R,Spada F,Clarkson R
13-0611-81 was used in Flow cytometry/Cell sorting to indicate that inhibiting the processing of p100 may be a potential therapeutic strategy to suppress cancer stem cell (CSC) activity in a subset of breast tumours.
Sat Apr 01 00:00:00 EDT 2017
Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.
Cancer research
Yeo SK,Wen J,Chen S,Guan JL
13-0611 was used in Flow cytometry/Cell sorting to identify the coexistence of distinct breast cancer stem-like cells based on their expression of ALDH(+) and CD29(hi)CD61(+) markers, which are differentially regulated by autophagy.
Wed Jun 01 00:00:00 EDT 2016
WISP1-αvβ3 integrin signaling positively regulates TLR-triggered inflammation response in sepsis induced lung injury.
Scientific reports
Chen Z,Ding X,Jin S,Pitt B,Zhang L,Billiar T,Li Q
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Neutralization
Tue Jun 28 00:00:00 EDT 2016
WISP1-αvβ3 integrin signaling positively regulates TLR-triggered inflammation response in sepsis induced lung injury.
Scientific reports
Chen Z,Ding X,Jin S,Pitt B,Zhang L,Billiar T,Li Q
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Neutralization
Tue Jun 28 00:00:00 EDT 2016
H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
Journal of hematology & oncology
Liu HD,Zhang AJ,Xu JJ,Chen Y,Zhu YC
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Immunofluorescence
Wed Feb 24 00:00:00 EST 2016
Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.
Nature
Gerber EE,Gallo EM,Fontana SC,Davis EC,Wigley FM,Huso DL,Dietz HC
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Flow Cytometry
Thu Nov 07 00:00:00 EST 2013
Notch2 genetic fate mapping reveals two previously unrecognized mammary epithelial lineages.
Nature cell biology
Šale S,Lafkas D,Artavanis-Tsakonas S
13-0611 was used in Flow cytometry/Cell sorting to study the fate of cells expressing the Notch2 receptor paralogue, uncovering two novel mammary epithelial cell linages.
Wed May 01 00:00:00 EDT 2013
Evidence for a multipotent mammary progenitor with pregnancy-specific activity.
Breast cancer research : BCR
Kaanta AS,Virtanen C,Selfors LM,Brugge JS,Neel BG
13-0611 was used in Flow cytometry/Cell sorting to provide data to show the existence of multi-potent mammary progenitor cells that have pregnancy-specific function.
Mon Dec 08 00:00:00 EST 2014
Evidence for a multipotent mammary progenitor with pregnancy-specific activity.
Breast cancer research : BCR
Kaanta AS,Virtanen C,Selfors LM,Brugge JS,Neel BG
13-0611 was used in Flow cytometry/Cell sorting to provide data to show the existence of multi-potent mammary progenitor cells that have pregnancy-specific function.
Mon Dec 08 00:00:00 EST 2014
β1 integrins with individually disrupted cytoplasmic NPxY motifs are embryonic lethal but partially active in the epidermis.
The Journal of investigative dermatology
Meves A,Stremmel C,Böttcher RT,Fässler R
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Flow Cytometry
Sun Dec 01 00:00:00 EST 2013
Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept.
PloS one
Kim S,Goel S,Alexander CM
Tue Apr 26 00:00:00 EDT 2011
Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling.
The Journal of biological chemistry
Pedroja BS,Kang LE,Imas AO,Carmeliet P,Bernstein AM
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Western Blot
Fri Jul 31 00:00:00 EDT 2009
Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling.
The Journal of biological chemistry
Pedroja BS,Kang LE,Imas AO,Carmeliet P,Bernstein AM
Published figure using CD61 (Integrin beta 3) monoclonal antibody (Product # 13-0611-81) in Western Blot
Fri Jul 31 00:00:00 EDT 2009
Constitutively active aryl hydrocarbon receptor expressed specifically in T-lineage cells causes thymus involution and suppresses the immunization-induced increase in splenocytes.
Journal of immunology (Baltimore, Md. : 1950)
Nohara K,Pan X,Tsukumo S,Hida A,Ito T,Nagai H,Inouye K,Motohashi H,Yamamoto M,Fujii-Kuriyama Y,Tohyama C
Tue Mar 01 00:00:00 EST 2005